Literature DB >> 9192949

Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature.

B Buyse1, E Michiels, R Bouillon, H Bobbaers, M Demedts.   

Abstract

Sleep apnoea syndrome (SAS) is common in acromegalic patients. Occasionally, the relief of apnoeas after treatment of the acromegaly has been documented. We report the cases of three patients with acromegaly and severe obstructive sleep apnoea, who demonstrated a manifest improvement (respiratory disturbance index (RDI) <20) after treatment with octreotide, indicating that this drug may be effective in this disturbance. In one case, SAS disappeared although the growth hormone level was not fully normalized. This raises the intriguing hypothesis that octreotide has an effect on respiratory control or on the upper airway, that is not directly related to its action on production of growth hormone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192949     DOI: 10.1183/09031936.97.10061401

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters.

Authors:  L Vannucci; P Luciani; E Gagliardi; S Paiano; R Duranti; G Forti; A Peri
Journal:  J Endocrinol Invest       Date:  2012-07-09       Impact factor: 4.256

Review 2.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

3.  Sleep-disordered breathing in Australian children with Prader-Willi syndrome following initiation of growth hormone therapy.

Authors:  Daan Caudri; Gillian M Nixon; Aleisha Nielsen; Linda Mai; Claire R Hafekost; Nitin Kapur; Chris Seton; Andrew Tai; Greg Blecher; Geoff Ambler; Philip B Bergman; Komal A Vora; Patricia Crock; Charles F Verge; Elaine Tham; Yassmin Musthaffa; Antony R Lafferty; Peter Jacoby; Andrew C Wilson; Jenny Downs; Catherine S Choong
Journal:  J Paediatr Child Health       Date:  2021-08-16       Impact factor: 1.929

4.  Craniofacial abnormalities, obesity, and hormonal alterations have similar effects in magnitude on the development of nocturnal hypoxemia in patients with acromegaly.

Authors:  M P Rodrigues; L A Naves; L A Casulari; C M Silva; W D Paula; M T Cabral; R R Araujo; C A Viegas
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.